Skip to content

7% Hypertonic Saline (HS)

DRUG2 trials

Sponsors

CF Therapeutics Development Network Coordinating Center, University of Washington, the Collaborative Health Studies Coordinating Center

Conditions

Cystic Fibrosis

Related Papers